Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

Intuitive Surgical clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our USA, Germany, UK, Switzerland, France, South Korea, Italy, Denmark, Norway, China and Japan registers with Intuitive Surgical as lead sponsor. Synced 12 Nov 2026
18Current trials
5Recruiting now
0Drugs in these trials
11Trial registers
At a glance

Intuitive Surgical is the lead sponsor of 18 current clinical trials in our USA, Germany, UK, Switzerland, France, South Korea, Italy, Denmark, Norway, China and Japan registers. 5 are recruiting patients now. The most common phase is Observational. The most-studied condition is Lung Cancer.

ClinicalTrials.gov trials by status

  • Recruiting528%
  • Not yet open16%
  • Active, closed1267%

Trials by phase

  • Observational950%
  • Not applicable739%
  • Phase 416%
  • Phase 316%
01

Clinical trials sponsored by Intuitive Surgical

18 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing Robotic-Assisted Bronchoscopy
NCT07761351 · Lung Cancer (Diagnosis), Lung Nodule
Phase 4 Recruiting 2026-08 UK, Germany, Switzerland
Lung cAncer Robotic Comparative Study
NCT06038227 · Lung Cancer
Observational Recruiting 2023-07 UK, Germany, France, Italy, Denmark, Switzerland, Norway
European Real-World Registry for Use of the Ion Endoluminal System
NCT06923774 · Pulmonary Nodule, Lung Cancer
Observational Recruiting 2025-09 UK, Germany, France, Switzerland
GENERATE - Next GENERATion of GynEcological Surgery - Robotic Assisted Surgery in Gynecological Indications
NCT05867927 · ClinicalTrials.gov ↗ · GYN Disorders
Observational Recruiting 2023-10 Germany
IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery
NCT07346066 · Ureter Injury
Phase 3 Recruiting 2026-05 USA
Robotic Bronchoscopy for Small Lung Nodules Without a Bronchus Sign
NCT07862816 · ClinicalTrials.gov ↗ · Lung Cancer (Diagnosis)
Observational Not yet open 2027-01 South Korea
da Vinci SP® Investigational Device Exemption Study in Colorectal Procedures
NCT04403022 · Colorectal Cancer, Benign or Malignant Rectal or Colon Tumors
Not applicable Active, closed 2021-06 USA, South Korea
Retrospective Acute Care Appendectomy Study
NCT06624215 · Acute Appendicitis
Observational Active, closed 2024-11 USA
CoSMAP Trial: SP-EA vs MP-TA Robot-Assisted Radical Prostatectomy
NCT07666217 · ClinicalTrials.gov ↗ · Prostate Cancer
Observational Active, closed 2026-03 Japan
Use of Force Feedback Instruments With the da Vinci Surgical System, Model IS5000 for Mitral Valve Repair
NCT07655505 · Mitral Regurgitation (MR)
Not applicable Active, closed 2026-07 USA
SP Thoracic IDE Study
NCT05150210 · Primary Lung Cancer, Benign Lung Disease, Thymoma
Not applicable Active, closed 2022-07 USA
A Trial to Compare Robotic Assisted Bronchoscopy Ion's Clinical Utility for Peripheral Lung Nodule Access and Diagnosis to ENB
NCT06308120 · ClinicalTrials.gov ↗ · Pulmonary Nodule, Solitary, Lung Cancer
Not applicable Active, closed 2024-03 China
Real World Registry for Use of the Ion Endoluminal System
NCT06004440 · Lung Cancer, Multiple Pulmonary Nodules, Lung Neoplasms
Observational Active, closed 2023-09 USA
Robotic vs. Open NSM for Early Stage Breast Cancer
NCT05720039 · Breast Cancer Female, Breast Cancer, Breast Cancer, Early-Onset
Not applicable Active, closed 2023-05 USA
Open Nipple Sparing Mastectomy (NSM)
NCT04447339 · Nipple Sparing Mastectomy
Observational Active, closed 2020-09 USA
Robotic-Assisted da Vinci System Prophylactic Nipple-Sparing Mastectomy
NCT03892980 · Nipple Sparing Mastectomy
Not applicable Active, closed 2021-03 USA
Clinical Investigation of the da Vinci Surgical System
NCT05682742 · Thymoma, Mediastinal Tumor, Gynecologic Disease
Not applicable Active, closed 2022-12 USA
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
NCT06879912 · Hernia, Inguinal, Hernia, Ventral, Colorectal
Observational Active, closed 2025-05 USA

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in Intuitive Surgical trials

31 conditions
Lung Cancer4Lung Cancer (Diagnosis)2Thymoma2Nipple Sparing Mastectomy2Lung Nodule1Pulmonary Nodule1Acute Appendicitis1Mitral Regurgitation (MR)1Primary Lung Cancer1Benign Lung Disease1Myasthenia Gravis1Multiple Pulmonary Nodules1Lung Neoplasms1Respiratory Tract Neoplasms1Breast Cancer Female1Breast Cancer1Breast Cancer, Early-Onset1Breast Disease1Colorectal Cancer1Benign or Malignant Rectal or Colon Tumors1Mediastinal Tumor1Gynecologic Disease1Gynecologic Cancer1Ureter Injury1
05

Questions about Intuitive Surgical trials

How many clinical trials does Intuitive Surgical sponsor?

Intuitive Surgical is the lead sponsor of 18 current trials on ClinicalTrials.gov in our USA, Germany, UK, Switzerland, France, South Korea, Italy, Denmark, Norway, China and Japan registers, as of the registry sync on 12 November 2026. Completed and withdrawn studies are not counted.

Are Intuitive Surgical trials recruiting?

Yes. 5 of its 18 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 12 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.